ArticleLeukemia research2011

Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells.

Omar Al Ustwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.